Redeye: CellaVision will release its Q2 report on July 16 and we expect to see a significant negative impact from the corona crisis on both sales and EBIT. However, we still have a positive long-term view and believe that short-term dips can provide good opportunities to buy the share. preview on CellaVision Q2.